{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:31:42Z","timestamp":1791304302071,"version":"4.3.1"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.schres.2026.04.016","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:33:14Z","timestamp":1777361594000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risk and management of cancer in clozapine users: A systematic review"],"prefix":"10.1016","volume":"294","author":[{"given":"H\u00e9l\u00e8ne","family":"Verdoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Lepetit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"de Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.04.016_bb0005","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1177\/0004867414539399","article-title":"Continuation of clozapine in a patient with lymphoma","volume":"48","author":"Ali","year":"2014","journal-title":"Aust. NZ J. Psych."},{"key":"10.1016\/j.schres.2026.04.016_bb0010","first-page":"2","article-title":"Hyperleukocytosis during clozapine treatment: a rare presentation of B-cell acute lymphoblastic leukemia","volume":"15","author":"Augustin","year":"2021","journal-title":"Leuk. Res. Rep."},{"key":"10.1016\/j.schres.2026.04.016_bb0015","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1176\/ajp.150.10.1562","article-title":"Clozapine, cancer and schizophrenia","volume":"150","author":"Avnon","year":"1993","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0025","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/pon.3779","article-title":"Clozapine therapy throughout myelosuppressive chemotherapy: regulations without standardization","volume":"24","author":"Barreto","year":"2015","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.schres.2026.04.016_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/met.2023.0048","article-title":"The effect of obesity and body mass index on hematologic malignancies","volume":"21","author":"Bilgihan","year":"2023","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.schres.2026.04.016_bb0035","first-page":"7","article-title":"Association between clozapine exposure and risk of hematologic malignancies in veterans with schizophrenia","volume":"85","author":"Brainerd","year":"2024","journal-title":"J Clin. Psych."},{"key":"10.1016\/j.schres.2026.04.016_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bcr-2020-238377","article-title":"Clozapine and chemotherapy: a dangerous couple or a necessary partnership?","volume":"13","author":"Campbell","year":"2020","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.schres.2026.04.016_bb0045","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/JCP.0000000000001900","article-title":"A case report and Mini review on clozapine treatment during chemotherapy is it possible to manage neutropenia successfully with secondary G-CSF?J","volume":"44","author":"Ceran","year":"2024","journal-title":"Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1192\/pb.bp.114.048306","article-title":"Chemotherapy for Hodgkin\u2019s lymphoma in a patient receiving clozapine for treatment-resistant schizophrenia: use of the mental capacity act 2005","volume":"39","author":"Chamberlain","year":"2015","journal-title":"BJPsych. Bull."},{"key":"10.1016\/j.schres.2026.04.016_bb0060","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ijc.31980","article-title":"New use for old drugs: the protective effect of atypical antipsychotics on hepatocellular carcinoma","volume":"144","author":"Chen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.schres.2026.04.016_bb0065","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S0033291720002317","article-title":"Response to \u2018the association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase\u2019","volume":"51","author":"Chr\u00e9tien","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.04.016_bb0070","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291720000161","article-title":"Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase(\u00ae)","volume":"51","author":"Chr\u00e9tien","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.04.016_bb0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","article-title":"Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll","year":"2022","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.psym.2014.05.007","article-title":"Continuation of clozapine during chemotherapy: a case report and review of literature","volume":"55","author":"Cunningham","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2026.04.016_bb0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/JCP.0000000000001699","article-title":"Hematological and other cancers in people using clozapine analysis of Australian spontaneous reports between 1995 and 2020","volume":"43","author":"Dawson","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0090","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2147\/PPA.S495254","article-title":"Pharmacovigilance in action: utilizing VigiBase data to improve clozapine safety","volume":"18","author":"de las Cuevas","year":"2024","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.schres.2026.04.016_bb0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/JCP.0000000000002088","article-title":"Fatal outcomes in use of clozapine: a VigiBase study of 6402 women and 11,222 men","volume":"45","author":"de Las Cuevas","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2025.104622","article-title":"The clozapine package inserts need to reflect lower doses for Asians","volume":"110","author":"de Leon","year":"2025","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2026.04.016_bb0105","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1017\/S0033291720001233","article-title":"The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase","volume":"51","author":"de Leon","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.04.016_bb0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2215-0366(22)00154-7","article-title":"Clozapine and the risk of haematological malignancies","volume":"9","author":"de Leon","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/JCP.0000000000001678","article-title":"Escaping the long shadow cast by agranulocytosis: reflections on clozapine pharmacovigilance focused on the United Kingdom","volume":"43","author":"de Leon","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0120","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/17425255.2024.2373111","article-title":"Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia","volume":"20","author":"de Leon","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.schres.2026.04.016_bb0125","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/JCP.0000000000001990","article-title":"Letter to the FDA proposing major changes in the US clozapine package insert supported by clozapine experts worldwide. Part II: a review of fatal outcomes in US pharmacovigilance data and proposed changes","volume":"45","author":"de Leon","year":"2025","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jagp.2025.08.010","article-title":"Comparative analysis of fatal outcomes in 5,370 geriatric vs. 12,254 non-geriatric adult patients: a clozapine study in VigiBase","volume":"34","author":"de Leon","year":"2026","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4103\/0019-5545.130507","article-title":"Clozapine and cancer treatment: adding to the experience and evidence","volume":"56","author":"Deodhar","year":"2014","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JCP.0000000000001651","article-title":"Hodgkin lymphoma in patients receiving clozapine treatment 2 case reports and literature review","volume":"43","author":"Dogan","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0145","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s11864-022-00976-y","article-title":"Constipation in Cancer patients - an update of clinical evidence","volume":"23","author":"Dzier\u017canowski","year":"2022","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.schres.2026.04.016_bb0150","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/archpsyc.1995.03950180094013","article-title":"Clozapine-associated postoperative ileus: case report and review of the literature","volume":"52","author":"Erickson","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0155","author":"European Medicines Agency (EMA)"},{"key":"10.1016\/j.schres.2026.04.016_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0326224","article-title":"A psychiatric medication, clozapine, induces autophagy and apoptosis in breast cancer cells through reactive oxygen species","volume":"20","author":"Fan","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2026.04.016_bb0165","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/ajh.23744","article-title":"The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies","volume":"89","author":"Fircanis","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.schres.2026.04.016_bb0170","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2468-2667(19)30187-2","article-title":"End-of-life care among patients with schizophrenia and cancer: a population-based cohort study from the French national hospital database","volume":"4","author":"Fond","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.schres.2026.04.016_bb0180","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1080\/10428194.2025.2461663","article-title":"Clozapine is associated with an increased risk of Hodgkin and non-Hodgkin lymphoma","volume":"66","author":"Frey","year":"2025","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.schres.2026.04.016_bb0185","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.pnpbp.2008.05.017","article-title":"Maintaining clozapine treatment during chemotherapy for non-Hodgkin's lymphoma","volume":"32","author":"Frieri","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/acps.70065","article-title":"Impact of schizophrenia Spectrum disorders on the receipt of invasive and systemic therapy for colorectal Cancer: a Nationwide multicenter retrospective cohort study in Japan","author":"Fujiwara","year":"2026","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.04.016_bb0195","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMp2500491","article-title":"The epidemic of tobacco harms among people with mental health conditions","volume":"393","author":"Gilbody","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2026.04.016_bb0200","article-title":"Lambda light chain multiple myeloma in a 47-year-old female patient on long-term clozapine therapy","volume":"17","author":"Goel","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.schres.2026.04.016_bb0205","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/pon.1267","article-title":"Case report: clozapine chemotherapy for lung given in the context of cancer","volume":"17","author":"Goulet","year":"2008","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.schres.2026.04.016_bb0210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/ejh.13285","article-title":"Feasibility of myelosuppressive chemotherapy in psychiatric patients on clozapine: a systematic review of the literature","volume":"103","author":"Grainger","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.schres.2026.04.016_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S1092852925100576","article-title":"Clozapine and anti-cancer agents: a systematic literature review of case reports","volume":"30","author":"Honor","year":"2025","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2026.04.016_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004457","article-title":"Rare but elevated incidence of hematological malignancy after clozapine use in schizophrenia: a population cohort study","volume":"21","author":"Hu","year":"2024","journal-title":"PLoS Med."},{"key":"10.1016\/j.schres.2026.04.016_bb0225","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1192\/bjp.178.6.576-a","article-title":"Reintroduction of clozapine after diagnosis of lymphoma","volume":"178","author":"Hundertmark","year":"2001","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0230","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ps.201900044","article-title":"Lung Cancer screening eligibility, risk perceptions, and clinician delivery of tobacco cessation among patients with schizophrenia","volume":"70","author":"Irwin","year":"2019","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2026.04.016_bb0235","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.lungcan.2010.05.002","article-title":"Solitary brain metastasis of an occult and stable small-cell lung cancer in a schizophrenic patient: a 3-year control","volume":"69","author":"Jesien-Lewandowicz","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.schres.2026.04.016_bb0240","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/pcn.13827","article-title":"Is clozapine use a risk of hematological malignancies? Insights from a meta-analysis \u201cclozapine and malignancy risk\u201d","volume":"79","author":"Kassar","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.04.016_bb0245","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/pcn.13856","article-title":"Response to comment on is clozapine use a risk of hematological malignancies? Insights from a meta-analysis \u201cclozapine and malignancy risk\u201d","volume":"79","author":"Kassar","year":"2025","journal-title":"P. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.04.016_bb0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamapsychiatry.2025.1155","article-title":"FDA eliminates the clozapine REMS-what comes next?","volume":"82","author":"Kelly","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0255","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/pon.3209","article-title":"Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine","volume":"22","author":"Kolli","year":"2013","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.schres.2026.04.016_bb0260","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.clml.2020.10.010","article-title":"Successful continuation of clozapine in conjunction with chimeric antigen receptor T-cell (CAR-T) immunotherapy: case report","volume":"21","author":"Kutzke","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.schres.2026.04.016_bb0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.schres.2017.12.019","article-title":"Lymphoma following clozapine exposure: more information needed","volume":"199","author":"Leung","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.04.016_bb0270","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1176\/jnp.2010.22.4.451.e4","article-title":"Continue or stop clozapine when patient needs chemotherapy?","volume":"22","author":"Liu","year":"2010","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.04.016_bb0275","first-page":"831","article-title":"Clozapine and chemotherapy. Hosp. Com","volume":"45","author":"McKenna","year":"1994","journal-title":"Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0280","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/0004867415621389","article-title":"Lymphoma developing during clozapine therapy","volume":"50","author":"Meltzer","year":"2016","journal-title":"Aust. NZ J. Psych."},{"key":"10.1016\/j.schres.2026.04.016_bb0285","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/pon.3744","article-title":"Clozapine and concomitant chemotherapy in a patient with schizophrenia and new onset esophageal cancer","volume":"24","author":"Monga","year":"2015","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.schres.2026.04.016_bb0290","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.941746","article-title":"Diffuse large B-cell lymphoma with cutaneous manifestations in a young patient using clozapine for schizophrenia: a case report","volume":"24","author":"Moraes de Brito","year":"2023","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.schres.2026.04.016_bb0295","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2147\/NDT.S49028","article-title":"Clozapine reinitiation following a \u201cred result\u201d secondary to chemotherapy","volume":"9","author":"Munshi","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2026.04.016_bb0300","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cpdd.937","article-title":"Evaluation of the effects of repeat-dose Dabrafenib on the single-dose pharmacokinetics of Rosuvastatin (OATP1B1\/1B3 substrate) and midazolam (CYP3A4 substrate)","volume":"10","author":"Nebot","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.schres.2026.04.016_bb0305","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.schres.2010.08.035","article-title":"Clozapine treatment associated with increased risk of acute myeloid leukemia (AML)","volume":"123","author":"Nielsen","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.04.016_bb0310","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/pcn.13839","article-title":"Comment on: is clozapine use a risk of hematological malignancies? Insights from a meta-analysis \u201cclozapine and malignancy risk\u201d","volume":"79","author":"Nishida","year":"2025","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.04.016_bb0315","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/JCP.0000000000000970","article-title":"Clozapine for the Management of Suicidal Behavior in borderline personality disorder complicated by a Cancer diagnosis: a case report and review of the literature","volume":"38","author":"O\u02bcLeary","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0320","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11096-016-0268-7","article-title":"Successful clozapine continuation during chemotherapy for the treatment of malignancy: a case report","volume":"38","author":"Overbeeke","year":"2016","journal-title":"Int. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0325","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.schres.2026.04.016_bb0330","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0019-5545.196711","article-title":"Use of clozapine alongside chemotherapy in a treatment-resistant bipolar disorder patient with ovarian carcinoma: a case report and brief review","volume":"58","author":"Pakhre","year":"2016","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0335","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602000044X","article-title":"The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study","volume":"29","author":"Pettersson","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.schres.2026.04.016_bb0340","first-page":"42","article-title":"Managing schizophrenia in a patient with cancer: a fine balance","volume":"16","author":"Riddle","year":"2017","journal-title":"Curr. Psychiatr. Ther."},{"key":"10.1016\/j.schres.2026.04.016_bb0345","article-title":"The impact of preexisting severe mental disorders on Cancer mortality: a systematic review and Meta-analysis","author":"Riis","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.04.016_bb0350","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1176\/appi.ajp.2007.06122021","article-title":"Restarting clozapine treatment during ablation chemotherapy and stem cell transplant for Hodgkin's lymphoma","volume":"164","author":"Rosenberg","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0355","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.ajp.161.1.175","article-title":"Clozapine therapy during cancer treatment","volume":"161","author":"Rosenstock","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0360","first-page":"419","article-title":"Clozapine, cancer chemotherapy and neutropenia - dilemmas in management","volume":"25","author":"Sankaranarayanan","year":"2013","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.schres.2026.04.016_bb0365","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/11587020-000000000-00000","article-title":"Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines","volume":"50","author":"Scheffler","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.schres.2026.04.016_bb0370","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(22)00149-3","article-title":"Clozapine and the risk of haematological malignancies","volume":"9","author":"Schulte","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0375","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S2215-0366(25)00098-7","article-title":"Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel","volume":"13","author":"Siskind","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0380","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2215-0366(19)30414-6","article-title":"Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4717839 people","volume":"7","author":"Solmi","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0390","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0395","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S2215-0366(21)00241-8","article-title":"Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland","volume":"8","author":"Taipale","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0400","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1002\/cam4.5456","article-title":"Increased risk of death from pneumonia among cancer survivors: a propensity score-matched cohort analysis","volume":"12","author":"Tanaka","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.schres.2026.04.016_bb0405","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/02698811241262767","article-title":"Severe neutropenia unrelated to clozapine in patients receiving clozapine","volume":"38","author":"Taylor","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0410","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/pon.5152","article-title":"Use of valproate and clozapine during course of chemoradiation in a patient with malignancy","volume":"28","author":"Tellez","year":"2019","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.schres.2026.04.016_bb0415","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S2215-0366(22)00204-8","article-title":"Clozapine and the risk of haematological malignancies - authors\u2019 reply","volume":"9","author":"Tiihonen","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0420","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S2215-0366(22)00044-X","article-title":"Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland","volume":"9","author":"Tiihonen","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0425","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00007691-200006000-00015","article-title":"Therapeutic drug monitoring of clozapine: an unexpected outcome","volume":"22","author":"Uges","year":"2000","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.schres.2026.04.016_bb0430","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/2045125314553610","article-title":"Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma","volume":"4","author":"Usta","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0435","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40801-024-00417-2","article-title":"Relationship between clozapine and non-hematological malignant tumors: a pharmacovigilance analysis using the FDA adverse event reporting system database","volume":"11","author":"Uwai","year":"2024","journal-title":"Drugs-Real World Outcomes"},{"key":"10.1016\/j.schres.2026.04.016_bb0440","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.schres.2024.03.023","article-title":"Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma","volume":"267","author":"van der Heide","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.04.016_bb0445","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.seminoncol.2022.03.002","article-title":"Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; a practical and universal tool for management","volume":"49","author":"van Leeuwen","year":"2022","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.schres.2026.04.016_bb0450","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2018.05.046","article-title":"Prescriber and institutional barriers and facilitators of clozapine use: a systematic review","volume":"201","author":"Verdoux","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.04.016_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","article-title":"Clinical determinants of fever in clozapine users and implications for treatment management: a narrative review","volume":"211","author":"Verdoux","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.04.016_bb0460","doi-asserted-by":"crossref","DOI":"10.1192\/j.eurpsy.2024.1816","article-title":"The time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European clozapine task force","volume":"68","author":"Verdoux","year":"2025","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0465","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/17512433.2025.2520926","article-title":"Clozapine for older adults with severe mental illness: a systematic review and expert recommendations for clinical practice","volume":"18","author":"Verdoux","year":"2025","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2026.04.016_bb0470","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/acps.70040","article-title":"Barriers to clozapine use in Europe: a new Hope","volume":"152","author":"Verdoux","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.04.016_bb0475","article-title":"Evaluation of 96 cases of apparent clozapine-induced severe neutropenia","volume":"7","author":"Wallman","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.04.016_bb0485","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bcr-2024-260170","article-title":"Lessons learnt in the end-of-life management of a hospice inpatient with advanced oropharyngeal cancer established on clozapine for treatment-resistant schizophrenia","volume":"17","author":"Williams","year":"2024","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.schres.2026.04.016_bb0490","doi-asserted-by":"crossref","first-page":"44","DOI":"10.12788\/cp.0254","article-title":"Should clozapine be discontinued in a patient receiving chemotherapy?","volume":"21","author":"Wright","year":"2022","journal-title":"Curr. Psychiatr."},{"key":"10.1016\/j.schres.2026.04.016_bb0495","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/pon.5782","article-title":"Successful continuation of clozapine treatment during hematopoietic stem cell transplantation: a step toward health equity in the oncologic care of people with severe mental illness","volume":"30","author":"Wright","year":"2021","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.schres.2026.04.016_bb0500","first-page":"6","article-title":"Clinically relevant drug interactions between anticancer drugs and psychotropic agents","volume":"20","author":"Yap","year":"2011","journal-title":"Eur. J. Cancer Care (Engl)"},{"key":"10.1016\/j.schres.2026.04.016_bb0505","doi-asserted-by":"crossref","first-page":"rjad105","DOI":"10.1093\/jscr\/rjad105","article-title":"Severe constipation causing ischaemic stercoral perforation of sigmoid colon","volume":"2023","author":"Zhang","year":"2023","journal-title":"J. Surg. Case Rep."},{"key":"10.1016\/j.schres.2026.04.016_bb0510","article-title":"Population-based study of long-term mortality risk associated with clozapine use among patients with schizophrenia","volume":"1-9","author":"Zhou","year":"2025","journal-title":"Br. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:24:54Z","timestamp":1781072694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":97,"alternative-id":["S0920996426001301"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.04.016","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk and management of cancer in clozapine users: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}